SB681323

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB681323, covering 2012-06-04 to 2012-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing